EHJ Editor-in-Chief/X
Aug 7, 2025, 05:52
Early Heparin in STEMI Care? EHJ Publishes Results of the Groundbreaking HELP-PCI Trial
EHJ Editor-in-Chief (Filippo Crea) posted on X:
”Could administering heparin at first medical contact improve outcomes in STEMI treatment? Read the results of HELP-PCI trial in EHJ.”
Read the full article here.
The HELP-PCI trial studied 999 STEMI patients undergoing PPCI to compare the timing of UFH administration—at first medical contact (FMC) vs in the Cath Lab.
Patients who received UFH at FMC had significantly better initial coronary blood flow (TFG-3: 23.6% vs 17.6%; OR 1.44; P = .02).
No differences were seen in 12-month MACCE, reperfusion success, or major bleeding.
Early UFH may improve pre-PPCI perfusion without added risk.
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial